12:00 AM
Jan 26, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Avastin bevacizumab: Phase III started

Last quarter, Genentech began the open-label Phase III ECOG 1305 trial to evaluate cisplatin plus docetaxel or fluorouracil with or without IV Avastin in 400...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >